Opus Genetics (IRD) Retained Earnings (2010 - 2026)
Opus Genetics (IRD) reported Retained Earnings of -$254.1 million for Q1 2026, down 72.65% year-over-year from -$929.1 million in Q1 2025, and down 34.75% on a QoQ basis from -$188.6 million in Q4 2025.
Opus Genetics (IRD) has 17 years of Retained Earnings data on file, last reported at -$254.1 million in Q1 2026.
- Quarterly Retained Earnings fell 72.65% year-over-year to -$254.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$254.1 million (down 72.65% YoY) and the FY2025 annual result came in at -$188.6 million, down 35.68% from the prior year.
- Retained Earnings declined to -$254.1 million in Q1 2026 per IRD's latest filing, from -$188.6 million in the prior quarter.
- Across five years, Retained Earnings topped out at -$71.5 million in Q4 2022 and bottomed at -$254.1 million in Q1 2026.
- The 5-year median for Retained Earnings is -$100.9 million (2022), against an average of -$119.7 million.
- The widest annual swing landed in 2023, when Retained Earnings increased 27.27%; it then plunged 72.65% in 2026.
- Tracing IRD's Retained Earnings over 5 years: stood at -$71.5 million in 2022, then dropped by 13.97% to -$81.5 million in 2023, then sank by 70.62% to -$139.0 million in 2024, then sank by 35.68% to -$188.6 million in 2025, then plunged by 34.75% to -$254.1 million in 2026.
- Per Business Quant, the three latest IRD Retained Earnings figures stand at -$254.1 million (Q1 2026), -$188.6 million (Q4 2025), and -$172.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 130.89 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 36.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | -254.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -254.12 Mn |
| Dec 31, 2025 | -188.59 Mn |
| Sep 30, 2025 | -172.07 Mn |
| Jun 30, 2025 | -154.61 Mn |
| Mar 31, 2025 | -147.19 Mn |
| Dec 31, 2024 | -139.00 Mn |
| Sep 30, 2024 | -103.86 Mn |
| Jun 30, 2024 | -96.34 Mn |
| Mar 31, 2024 | -88.57 Mn |
| Dec 31, 2023 | -81.47 Mn |
| Sep 30, 2023 | -76.67 Mn |
| Jun 30, 2023 | -82.23 Mn |
| Mar 31, 2023 | -77.27 Mn |
| Dec 31, 2022 | -71.48 Mn |
| Sep 30, 2022 | -105.42 Mn |
| Jun 30, 2022 | -100.89 Mn |
| Mar 31, 2022 | -95.96 Mn |
| Dec 31, 2021 | -89.37 Mn |
| Sep 30, 2021 | -83.06 Mn |
| Jun 30, 2021 | -78.83 Mn |
| Mar 31, 2021 | -71.69 Mn |
| Dec 31, 2020 | -32.68 Mn |
| Sep 30, 2020 | -167.82 Mn |
| Jun 30, 2020 | -166.42 Mn |
| Mar 31, 2020 | -163.91 Mn |
| Dec 31, 2019 | -8.06 Mn |
| Sep 30, 2019 | -161.45 Mn |
| Jun 30, 2019 | -159.49 Mn |
| Mar 31, 2019 | -12,602.00 |
| Dec 31, 2018 | -154.69 Mn |
| Sep 30, 2018 | -151.57 Mn |
| Jun 30, 2018 | -64,955.00 |
| Mar 31, 2018 | -89,376.00 |
| Dec 31, 2017 | -140.32 Mn |
| Sep 30, 2017 | -136.73 Mn |
| Jun 30, 2017 | -25,705.00 |
| Mar 31, 2017 | -6,326.00 |
| Dec 31, 2016 | -6,122.00 |
| Sep 30, 2016 | -114.50 Mn |
| Jun 30, 2016 | -111.63 Mn |
| Mar 31, 2016 | -1,406.00 |
| Dec 31, 2015 | -105.72 Mn |
| Sep 30, 2015 | -102.86 Mn |
| Jun 30, 2015 | -98.84 Mn |
| Mar 31, 2015 | 1,076.00 |
| Dec 31, 2014 | -91.33 Mn |
| Sep 30, 2014 | -42,041.00 |
| Jun 30, 2014 | -87.22 Mn |
| Mar 31, 2014 | 87.41 Mn |
| Dec 31, 2013 | -72.81 Mn |
| Sep 30, 2013 | 70.09 Mn |
| Jun 30, 2013 | 67.95 Mn |
| Mar 31, 2013 | 64.84 Mn |
| Dec 31, 2012 | 63.31 Mn |
| Sep 30, 2012 | 63.26 Mn |
| Jun 30, 2012 | 60.27 Mn |
| Mar 31, 2012 | 59.22 Mn |
| Dec 31, 2011 | 57.08 Mn |
| Sep 30, 2011 | 57.47 Mn |
| Jun 30, 2011 | 56.00 Mn |
| Dec 31, 2010 | 45.74 Mn |